APA (7th ed.) Citation

Y, T., T, J., T, K., N, Y., T, S., K, S., . . . Y, A. (2026). Low reticulocyte count at infusion is a risk factor for ICANS in CAR-T cell therapy. Cytotherapy, 28(5), 102065. https://doi.org/10.1016/j.jcyt.2026.102065

Chicago Style (17th ed.) Citation

Y, Tashiro, et al. "Low Reticulocyte Count at Infusion Is a Risk Factor for ICANS in CAR-T Cell Therapy." Cytotherapy 28, no. 5 (2026): 102065. https://doi.org/10.1016/j.jcyt.2026.102065.

MLA (9th ed.) Citation

Y, Tashiro, et al. "Low Reticulocyte Count at Infusion Is a Risk Factor for ICANS in CAR-T Cell Therapy." Cytotherapy, vol. 28, no. 5, 2026, p. 102065, https://doi.org/10.1016/j.jcyt.2026.102065.